Palliative Care: Industry and Academia – Tensions and Opportunities
Palliative Care: Industry and Academia – Tensions and Opportunities
Language and understanding: The complexity of insight in cancer care
Decolonising palliative care
Understanding patient experience in Europe: The first Global Lung Cancer Coalition Patient Experience Survey
CONVERT trial: Patterns of relapse following thoracic radiotherapy in patients with limited-stage SCLC
First-line osimertinib in EGFR mutant aNSCLC patients: Progression pattern and safety in the real-world
Phase III randomised trial comparing tebentafusp with investigator’s choice in first-line metastatic uveal melanoma
Randomised phase III study of copanlisib plus rituximab vs rituximab/placebo in relapsed indolent non-Hodgkin lymphoma
Healthy lifestyle may offset risk of lethal prostate cancer in men with high genetic risk
First-line pembrolizumab plus chemotherapy for patients with advanced squamous NSCLC: 3-year follow-up from KEYNOTE-407
MERMAID-2: Phase 3 study of durvalumab in patients with resected stage MRD II-III NSCLC
Real world data and diagnostics in patients with NSCLC with EGFR exon 20 insertions